1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism

Immunobiology

Volumn 217, Issue 12, 2012, Pages 1292-1300

  Korf, Hannelie ^a   Wenes, Mathias ^a   Stijlemans, Benoit ^b,c   Takiishi, Tatiana ^a   Robert, Sofie ^a   Miani, Michela ^d   Eizirik, Decio L ^d   Gysemans, Conny ^a   Mathieu, Chantal ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Inflammation; Macrophage; Type 1 diabetes; Vitamin D

Indexed keywords

CALCITRIOL; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12P40; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; EXPERIMENTAL DIABETES MELLITUS; FEMALE; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; CALCITRIOL; CELLS, CULTURED; CHEMOKINES, CXC; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84869079878     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.07.018     Document Type: Article

References (50)

1. Alleva D.G., Pavlovich R.P., Grant C., Kaser S.B., Beller D.I. Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes 2000, 49:1106-1115.
2. Alroy I., Towers T.L., Freedman L.P. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 1995, 15:5789-5799.
3. Arnush M., Scarim A.L., Heitmeier M.R., Kelly C.B., Corbett J.A. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J. Immunol. 1998, 160:2684-2691.
4. Baeke F., Korf H., Overbergh L., Verstuyf A., Thorrez L., Van Lommel L., Waer M., Schuit F., Gysemans C., Mathieu C. The vitamin D analog, TX527, promotes a human CD4+CD25 highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J. Immunol. 2011, 186:132-142.
5. Baeke F., Takiishi T., Korf H., Gysemans C., Mathieu C. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 2010, 10:482-496.
6. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F., de Waal-Malefyt R., Coffman R.L., Hawrylowicz C.M., O'Garra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002, 195:603-616.
7. Boonstra A., Barrat F.J., Crain C., Heath V.L., Savelkoul H.F., O'Garra A. 1Alpha, 25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol. 2001, 167:4974-4980.
8. Buckner J., Kwok W.W., Nepom B., Nepom G.T. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions. J. Immunol. 1996, 157:4940-4945.
9. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., Garland C.F., Giovannucci E. Epidemic influenza and vitamin D. Epidemiol. Infect. 2006, 134:1129-1140.
10. Carrasco-Marin E., Shimizu J., Kanagawa O., Unanue E.R. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 1996, 156:450-458.
11. Castrillo A., Joseph S.B., Vaidya S.A., Haberland M., Fogelman A.M., Cheng G., Tontonoz P. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell 2003, 12:805-816.
12. D'Ambrosio D., Cippitelli M., Cocciolo M.G., Mazzeo D., Di Lucia P., Lang R., Sinigaglia F., Panina-Bordignon P. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3, Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 1998, 101:252-262.
13. Dahlen E., Dawe K., Ohlsson L., Hedlund G. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J. Immunol. 1998, 160:3585-3593.
14. Devaraj S., Tobias P., Kasinath B.S., Ramsamooj R., Afify A., Jialal I. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1796-1804.
15. Ferreira G.B., van Etten E., Verstuyf A., Waer M., Overbergh L., Gysemans C., Mathieu C. 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. Diabetes Metab. Res. Rev. 2011, 27:933-941.
16. Fleet J.C. Molecular regulation of calcium and bone metabolism through the vitamin D receptor. J. Musculoskelet. Neuronal. Interact. 2006, 6:336-337.
17. Fujita H., Asahina A., Komine M., Tamaki K. The direct action of 1alpha, 25(OH)2-vitamin D3 on purified mouse Langerhans cells. Cell. Immunol. 2007, 245:70-79.
18. Garland C.F., Garland F.C., Gorham E.D., Lipkin M., Newmark H., Mohr S.B., Holick M.F. The role of vitamin D in cancer prevention. Am. J. Public Health 2006, 96:252-261.
19. Heine G., Niesner U., Chang H.D., Steinmeyer A., Zugel U., Zuberbier T., Radbruch A., Worm M. 1,25-Dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur. J. Immunol. 2008, 38:2210-2218.
20. Helming L., Bose J., Ehrchen J., Schiebe S., Frahm T., Geffers R., Probst-Kepper M., Balling R., Lengeling A. 1Alpha, 25-dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 2005, 106:4351-4358.
21. Hutchings P., Rosen H., O'Reilly L., Simpson E., Gordon S., Cooke A. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 1990, 348:639-642.
22. Jun H.S., Yoon C.S., Zbytnuik L., van Rooijen N., Yoon J.W. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 1999, 189:347-358.
23. Kanter J.E., Kramer F., Barnhart S., Averill M.M., Vivekanandan-Giri A., Vickery T., Li L.O., Becker L., Yuan W., Chait A., et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E715-E724.
24. Korf J., Stoltz A., Verschoor J., De Baetselier P., Grooten J. The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses. Eur. J. Immunol. 2005, 35:890-900.
25. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996, 14:233-258.
26. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
27. Lyakh L.A., Sanford M., Chekol S., Young H.A., Roberts A.B. TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells. J. Immunol. 2005, 174:2061-2070.
28. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
29. Mathieu C., Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol. Metab. 2005, 16:261-266.
30. Matilainen J.M., Husso T., Toropainen S., Seuter S., Turunen M.P., Gynther P., Yla-Herttuala S., Carlberg C., Vaisanen S. Primary effect of 1alpha, 25(OH)D on IL-10 expression in monocytes is short-term down-regulation. Biochim. Biophys. Acta 2010, 1803:1276-1286.
31. Overbergh L., Decallonne B., Valckx D., Verstuyf A., Depovere J., Laureys J., Rutgeerts O., Saint-Arnaud R., Bouillon R., Mathieu C. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin. Exp. Immunol. 2000, 120:139-146.
32. Overbergh L., Stoffels K., Waer M., Verstuyf A., Bouillon R., Mathieu C. Immune regulation of 25-hydroxyvitamin D-1alpha-hydroxylase in human monocytic THP1 cells: mechanisms of interferon-gamma-mediated induction. J. Clin. Endocrinol. Metab. 2006, 91:3566-3574.
33. Penna G., Adorini L. 1Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 2000, 164:2405-2411.
34. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
35. Prietl B., Pilz S., Wolf M., Tomaschitz A., Obermayer-Pietsch B., Graninger W., Pieber T.R. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases?. Isr. Med. Assoc. J. 2010, 12:136-139.
36. Provvedini D.M., Tsoukas C.D., Deftos L.J., Manolagas S.C. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983, 221:1181-1183.
37. Sadeghi K., Wessner B., Laggner U., Ploder M., Tamandl D., Friedl J., Zugel U., Steinmeyer A., Pollak A., Roth E., et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol. 2006, 36:361-370.
38. Schauber J., Dorschner R.A., Coda A.B., Buchau A.S., Liu P.T., Kiken D., Helfrich Y.R., Kang S., Elalieh H.Z., Steinmeyer A., et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 2007, 117:803-811.
39. Sen P., Bhattacharyya S., Wallet M., Wong C.P., Poligone B., Sen M., Baldwin A.S., Tisch R. NF-kappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages. J. Immunol. 2003, 170:1770-1780.
40. Serreze D.V., Gaedeke J.W., Leiter E.H. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:9625-9629.
41. Sochorova K., Budinsky V., Rozkova D., Tobiasova Z., Dusilova-Sulkova S., Spisek R., Bartunkova J. Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells. Clin. Immunol. 2009, 133:69-77.
42. Stio M., Martinesi M., Bruni S., Treves C., Mathieu C., Verstuyf A., d'Albasio G., Bagnoli S., Bonanomi A.G. The vitamin D analogue TX 527 blocks NF-kappaB activation in peripheral blood mononuclear cells of patients with Crohn's disease. J. Steroid Biochem. Mol. Biol. 2007, 103:51-60.
43. Stoffels K., Overbergh L., Bouillon R., Mathieu C. Immune regulation of 1alpha-hydroxylase in murine peritoneal macrophages: unravelling the IFNgamma pathway. J. Steroid Biochem. Mol. Biol. 2007, 103:567-571.
44. Stoffels K., Overbergh L., Giulietti A., Kasran A., Bouillon R., Gysemans C., Mathieu C. NOD macrophages produce high levels of inflammatory cytokines upon encounter of apoptotic or necrotic cells. J. Autoimmun. 2004, 23:9-15.
45. Stoffels K., Overbergh L., Giulietti A., Verlinden L., Bouillon R., Mathieu C. Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J. Bone Miner. Res. 2006, 21:37-47.
46. Uno S., Imagawa A., Okita K., Sayama K., Moriwaki M., Iwahashi H., Yamagata K., Tamura S., Matsuzawa Y., Hanafusa T., et al. Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes. Diabetologia 2007, 50:596-601.
47. van Etten E., Dardenne O., Gysemans C., Overbergh L., Mathieu C. 1,25-Dihydroxyvitamin D3 alters the profile of bone marrow-derived dendritic cells of NOD mice. Ann. N. Y. Acad. Sci. 2004, 1037:186-192.
48. Veldman C.M., Cantorna M.T., DeLuca H.F. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch. Biochem. Biophys. 2000, 374:334-338.
49. Zasloff M. Inducing endogenous antimicrobial peptides to battle infections. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:8913-8914.
50. Zhang Y., Leung D.Y., Richers B.N., Liu Y., Remigio L.K., Riches D.W., Goleva E. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J. Immunol. 2012, 188:2127-2135.